Clinical Trials Logo

Type1diabetes clinical trials

View clinical trials related to Type1diabetes.

Filter by:

NCT ID: NCT04550585 Completed - Type1diabetes Clinical Trials

Specialized Technology Education for Pumps & Pens in Underserved Populations With Diabetes

STEPP-UP
Start date: April 1, 2017
Phase:
Study type: Observational

Lower socioeconomic status (SES) individuals with type 1 diabetes have poorer outcomes than wealthier patients and part of this disparity comes from a lack of tools and knowledge about how to teach these patients on the technologies other patients take for granted. Therefore, this is a study designed to develop and test low literacy English/Spanish language teaching tools for patients with type 1 diabetes treated with varying types of technology in the Los Angeles County healthcare system. The aims are to:To reduce health disparities for underserved adults with diabetes on multiple daily injection (MDI) therapy using vials and syringes through the use of a simplified lower literacy, culturally and language appropriate approach to teach, implement and follow these individuals started on insulin pens and pumps/continuous subcutaneous insulin infusion (CSII); To show no increase in rates of diabetic ketoacidosis (DKA) or severe hypoglycemia when using CSII or pen therapy compared to baseline rates; To reduce time spent in hyper and hypoglycemic ranges, as well as glycemic variability, as measured by blinded continuous glucose monitoring (CGM); Reduce psychological distress due to diabetes and improve health-related quality of life, as measured by validated distress and quality of life scales. Secondary Aims include: Reduction in A1C levels with CSII/pen therapy compared to standard MDI treatment; and to perform a cost-analysis of the process of implementation to improve the generalizability of the model.

NCT ID: NCT04512885 Completed - Type1diabetes Clinical Trials

Study of Acceptability of a New Distance-learning Tool "MyFIT"

MyFIT
Start date: July 16, 2020
Phase:
Study type: Observational

The investigators developed an on-line learning tool "MyFIT" enabling to patients with T1D to acquire the knowledge and skills for practicing functional insulin therapy from their home. The aim of the present study is to evaluate the acceptability of this new learning modality via the tool "MyFIT" by the patients and by the health professionnals.

NCT ID: NCT04479826 Completed - type1diabetes Clinical Trials

Unannounced Meal Handling of Advanced Closed Loop Insulin Delivery in Monitored Condition

Start date: July 16, 2020
Phase: N/A
Study type: Interventional

The study will follow participants for the periods of 3 months while using an advanced hybrid closed loop algorithm in free living conditions . Each period will have a different meal handling protocols. The objective is to identify the mitigation of the algorithm with different meal handling approaches.

NCT ID: NCT04450745 Completed - type1diabetes Clinical Trials

Physical Exercise in Normobaric Hypoxia and Normoxia in Type 1 Diabetic Patients

Start date: October 30, 2019
Phase: N/A
Study type: Interventional

Physical activity, along with proper nutrition, is the basis for the behavioral treatment of diabetes. In recent years exercise training in normobaric hypoxia is used in training programs for athletes and in rehabilitation. The aim of this study is the assessment of physical exercise in normobaric hypoxia condition on metabolic control of diabetes: blood glucose profile, its stability, HbA1c value, hypoglycemia: frequency, level, severity and time of occurrence, insulin demand, maximal muscle strength level, VO2max and anthropometric parameters.

NCT ID: NCT04384471 Completed - Covid19 Clinical Trials

Covid-19 Pandemic: Patients' Experience in T1D

Start date: April 29, 2020
Phase:
Study type: Observational

Given the current situation with COVID-19 declared pandemic on March 11, 2020 and the requirement for physical distancing and to limit social interactions, and for some, to quarantine, the investigators will survey patients living with type 1 diabetes (and their families, if they are <18 years) about their current experience with their diabetes management to understand their needs. The primary objective is to describe the exposition and the impact of COVID-19 pandemic on type 1 diabetes. The investigators will recruit people with type 1 diabetes from all ages living in Quebec to answer a short online survey.

NCT ID: NCT04383990 Completed - Type1diabetes Clinical Trials

Early Versus Late Administration of Insulin Glargine in T1DM During Fasting Ramadan

Start date: February 28, 2020
Phase: N/A
Study type: Interventional

To compare different timing of insulin Glargine administration (early-6 pm versus standard bedtime-10 pm) as part of standard of care in patients with type1 diabetes who wish to fast the month of Ramadan.

NCT ID: NCT04208282 Completed - Type1diabetes Clinical Trials

Safety and Efficacy of 7-day Wear Infusion Set vs. Control Infusion Set.

Start date: July 1, 2017
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the Extended Wear (EW) infusion set seven day functioning in patients with Type 1 diabetes compared to the Quick-set infusion set. The study will be carried out in adults with type 1 diabetes.

NCT ID: NCT04204733 Completed - Type1diabetes Clinical Trials

Mobile Physical Activity for Type 1 Diabetes

Start date: January 6, 2020
Phase: N/A
Study type: Interventional

The study is the formative observation stage of behavioral intervention development. Sedentary adults with type 1 diabetes will be given access to a mobile application that incorporates biosensor feedback, teleconsultation, and online group exercise classes. The first aim is to quantify the feasibility, acceptability, and preliminary efficacy of the application. The second aim is to evaluate predictors and mechanisms of physical activity behavior change among these adults. The possible predictors the investigators are monitoring include usage of specific application features, momentary internal factors (e.g., pre-activity fear of hypoglycemia), momentary external factors (e.g., location), and latent external factors (e.g., mental health traits). These results will be used to develop a refined mobile application utilizing the most popular application features, as well as an algorithm that uses the identified predictors of physical activity to advise adults with type 1 diabetes when to engage in physical activity (i.e., context-aware physical activity coaching) and when to make related diet and insulin adjustments.

NCT ID: NCT04172077 Completed - Type1diabetes Clinical Trials

Self Efficacy Levels, Attachment Style and Resiliency of Youth With Type 1 Diabetes

Start date: September 18, 2019
Phase:
Study type: Observational

This project will assess self-efficacy levels(SE) ,resiliency and attachment style of adolescent with type 1 diabetes and their caregivers.SE and attachment style of patients and parents will be compared with each other as well as correlated with diabetes management as assessed by A1C and self inventory scale.

NCT ID: NCT04162067 Completed - Type1diabetes Clinical Trials

The Current Health Status of Patients Living With Type 1 Diabetes From the LMC Diabetes Patient Registry

Start date: January 6, 2020
Phase:
Study type: Observational

This retrospective study uses the Canadian LMC Diabetes Registry to describe the current health status of Canadians with type 1 diabetes. The study provides a detailed report of the demographic composition, treatment regimens, self-care approaches, health status, metabolic outcomes, and glycemic control of a large Canadian community-based, specialist-led cohort of patients with type 1 diabetes. Specific study outcomes will also be evaluated in a subgroup of patients using continuous subcutaneous insulin infusion (CSII) therapy.